Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2013 Sep 3;139(10):10.1007/s00432-013-1501-6. doi: 10.1007/s00432-013-1501-6

Figure 4. Receiver operating characteristic (ROC) curves discriminating ovarian cancer from benign controls.

Figure 4

The ROC curves for selected autoantibody markers for ovarian cancer were generated using GraphPad Prism 5. Area under the ROC curve (AUC) with 95% confidence intervals (CI) was calculated and a P-value of ≤ 0.05 was considered to be statistically significant.